Dividends Calendar Earnings Calendar
ICPT

ICPT | Intercept Pharma

Intercept Pharma
Category: Company
  • Industry: Drug Manufacturers - Major

Quick infos

  • Headquarters:   United States of America

Trade prices

  • Volume:
  • Market Cap: 708.01M
  • Prev closed: 39.65
  • Open: 39.9
  • High: 40.41
  • Low: 38.96
  • 52 week low: 38.96
  • 52 week high: 125
  • Dividends:No Dividends

Next ER: May 6, 2021  Before Market Opens



Top Stories (ICPT)

    About the Company

    Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases, such as primary biliary cirrhosis (PBC) now called primary biliary cholangitis, non-alcoholic fatty liver disease (or non-alcoholic steatohepatitis, NASH), cirrhosis, portal hypertension, primary sclerosing cholangitis and also the intestinal disorder, bile acid diarrhea.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    May 6, 2021- / -1.56- / 84.25M
    February 25, 2021-1.58 / -1.4883.27M / 85.03M
    November 9, 2020-2.01 / -1.9979.52M / 78.67MBeat!
    August 10, 2020-1.92 / -2.8877.25M / 72.45MBeat!
    July 30, 2020- / -2.94- / 72.01M
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Jun 14, 2021 22.32 21.70
    22.32
    21.70
    80.94K 3.53%
    Jun 11, 2021 21.56 21.51
    21.90
    20.91
    556.02K 0.28%
    Jun 10, 2021 21.50 21.35
    21.93
    20.88
    878.13K 0.47%
    Jun 9, 2021 21.40 20.27
    21.62
    20.16
    1.21M 7.86%
    Jun 8, 2021 19.84 19.48
    19.89
    18.78
    675.30K 3.33%
    Jun 7, 2021 19.20 18.20
    19.34
    17.70
    1.19M 6.61%
    Jun 4, 2021 18.01 17.90
    18.18
    17.60
    533.98K 0.50%
    Jun 3, 2021 17.92 17.57
    18.22
    17.22
    700.86K 2.22%
    Jun 2, 2021 17.53 17.41
    17.88
    17.22
    874.30K 2.16%
    Jun 1, 2021 17.16 16.60
    17.30
    16.52
    760.47K 3.19%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2002
    • Employees:456

    News

    News for (ICPT)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Mark E. Pruzanski, MD
    • Chief Human Resources Officer :  David Ford

    Talk about Intercept Pharma below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on May 6, 2021 (Same day)

    ntdoy hain syna sq gpro clls trip w rmax k expe y 


    Jump to (Finance sites)

    Their Official Profiles 

    WikipediaTwitterLinkedIn

    Peers / Similar stocks 

    xlv gild lly bmy 

    Other stocks 

    mcd snap fb jnj t bac ual low vfc xlnx dwdp five 

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    The Intelligent Investor
    Buy on Amazon

    Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.

    The best book on investing ever written.
    -- Warren Buffet